BSECompany Update3d ago · 5 Aug 2026, 04:03 pm
Gland Pharma announces strategic collaboration with Neuland Laboratories for sterile API Manufacturing
Gland Pharma Ltd · 543245
✦ AI Summary▲ PositiveM&A
Gland Pharma Ltd has announced a strategic collaboration with Neuland Laboratories for sterile API manufacturing. The partnership will enable Gland Pharma to expand its sterile manufacturing capacity and serve growing demand for sterile injectables in the global market.
Analysis Scores
Earnings Impact2/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release